June 6, 2017 09:25 AM EDT
R&D

AS­CO17: Chi-Med spot­lights pos­i­tive colon can­cer da­ta as part­ner Eli Lil­ly preps land­mark Chi­na roll­out

John Carroll

Editor & Founder

Hutchi­son Chi­na MediTech has tak­en an­oth­er step for­ward in a ma­jor rite of pas­sage for this ground­break­ing Chi­nese biotech. The com­pa­ny ar­rived at AS­CO with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times